Pink SheetIn what it describes as a “substantial boost” for the UK’s vaccine manufacturing capacity, the government has announced an additional £100m (US$130m) in funding for a state-of-the-art production cente
ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AbbVie Opts Not To Continue Leber Conge
ScripRising evidence that interferons could be used as potential treatments for COVID-19 led last month to Canada-based BetterLife Pharma Inc. acquiring Altum Pharmaceuticals Inc. , giving it ownership